Merck news
Latest News From Merck Pharmaceutical Company
Another Study Questions Utility Of Merck Cholesterol Drugs
Another Study Questions Utility Of Merck Cholesterol Drugs
Wall Street Journal - 58 minutes ago
By Peter Loftus Of DOW JONES NEWSWIRES A new study by health insurer UnitedHealth Group Inc. (UNH) concludes Merck & Co.'s (MRK) cholesterol drug Vytorin didn't significantly reduce the risk of ...
Pharma heavyweight joins Warburg Pincus
Pharma heavyweight joins Warburg Pincus
Private Equity News - 2 minutes ago
Fred Hassan, who stepped down as chief executive of Schering-Plough after the drug maker was acquired by Merck & Co. (MRK) earlier this month, has become a senior adviser to private equity firm ...
Merck's new CP wins S&P's top-notch short-term rating
Merck's new CP wins S&P's top-notch short-term rating
Trading Markets - 55 minutes ago
Nov 17, 2009 (M2 EQUITYBITES via COMTEX) -- MRK -- 17 November 2009 Acae" S&P on Monday gave its highest short-term rating of A-1+ to the new 4(2) commercial paper (CP) programme of Merck (NYSE ...
Former Schering CEO Becomes Senior Adviser To Warburg Pincus
Former Schering CEO Becomes Senior Adviser To Warburg Pincus
Wall Street Journal - 12 minutes ago
By Peter Loftus Of DOW JONES NEWSWIRES Fred Hassan, who stepped down as chief executive of Schering-Plough after the drug maker was acquired by Merck & Co. (MRK) earlier this month, has become a ...
Higher Dose of Merck's COZAAR® (losartan potassium tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational Study
Higher Dose of Merck's COZAAR® (losartan potassium tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational Study
Merck Reports Investigational Anacetrapib Phase IIb Study Results - Quick Facts
Merck Reports Investigational Anacetrapib Phase IIb Study Results - Quick Facts
RTT News - 13 minutes ago
(RTTNews) - Merck & Co. Inc. (MRK: News ) said that in a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co ...
Merck & Co., Inc. Announces Higher Dose Of Merck`s COZAAR Significantly Reduced Deaths And Hospitalizations Due To Heart Failure In Investigational Study
Competition Bureau Resolves Issues in Merger of Merck and Schering-Plough
Competition Bureau Resolves Issues in Merger of Merck and Schering-Plough
Linex Legal - 44 minutes ago
Source: Competition Bureau - The Competition Bureau announced today [October 29, 2009] that it has reached an agreement with Merck & Co., Inc. and Schering-Plough Corporation to resolve ...
